Clinical Trials Directory

Trials / Unknown

UnknownNCT02035501

Treatment of TNNT1-Myopathy With L-Tyrosine.

Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers

Summary

The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.

Conditions

Interventions

TypeNameDescription
DRUGL-Tyrosine
DRUGPlacebo

Timeline

Start date
2014-01-01
Primary completion
2015-01-01
First posted
2014-01-14
Last updated
2014-01-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02035501. Inclusion in this directory is not an endorsement.